Date Initiated by Firm |
December 14, 2017 |
Create Date |
May 10, 2018 |
Recall Status1 |
Terminated 3 on December 03, 2020 |
Recall Number |
Z-1796-2018 |
Recall Event ID |
79468 |
Product Classification |
Lipase-esterase, enzymatic, photometric, lipase - Product Code CHI
|
Product |
Dimension Lipase Flex¿ Reagent Cartridge - ( Lipase-esterase, enzymatic, photometric, lipase) |
Code Information |
Catalog DF56 Lot FB8109- UDI# (01)00842768025532(10)FB8109(17)20180419 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 Gbc Dr Ms 514 Po Box 6101 Newark DE 19702-2466
|
For Additional Information Contact |
Heydi Calderon 800-441-9250
|
Manufacturer Reason for Recall |
Calibration failure - confirmed a positive bias with LIPL lot FB8109 when compared to other Dimension LIPL lots. Lot FB8109 is not meeting Siemens internal specifications for lot-to-lot limits.
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
Customers are instructed to:
- Discontinue use of Dimension LIPL Assay lot FB8109.
¿- Recalibrate with an alternate lot of Dimension LIPL Assay.
¿- Review their inventory of this lot to determine their laboratory¿fs no-charge replacement needs.
¿- Review the UMDR/UFSN letter with their Medical Director.
¿- Complete and return the Field Correction Effectiveness Check Form attached to the UMDR/UFSN letter within 30 days.
- If they have received any complaints of illness or adverse events associated with lot FB8109, immediately contact their local Siemens Customer Care Center or their local Siemens Technical Support Representative |
Distribution |
Domestic and Foreign consignees |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|